Survival analysis on these post-therapy residual tumor cells overexpressed genes in the TARGET AML-1 dataset showed significant association with poor OS as well as lower EFS (Supplementary Fig. 24, Supplementary Table 10). Here, RUNX1 is linked to neoplasm.